ARCHIVES

FDA Ceases Exclusion Of Women From Early Drug Studies

This article is from The Cancer Letter archive.

Vol. 19 No. 19 | May 7, 1993

Download PDF Visit The Full Archive

Related Articles

Bloch Dissatisfied With PDQ, Offers $1 Million To fund “Tailored” Treatment Data To Physicians

November 13, 1987

ORI Finds Researcher Falsified Records

February 9, 1996

Amgen Replaces “Bundling” Contract With Three Separate Contracts For Growth Factors.

September 5, 2008

Mammography Screening Effective In Women Under 50: BCDDP

September 25, 1987

DCCP Recompetitions Approved Board Asks Others At NIH To Help Pay For Some Resources

October 24, 1980

DeVita To Discuss NCI Plans for CCOPs at ACCC Meetings

January 17, 1986